Professor Andrea Cavalli is the Director of CECAM (Centre Européen de Calcul Atomique et Moléculaire) at EPFL in Lausanne, Switzerland. His research integrates computational physics and chemistry with drug discovery, primarily focusing on cancer. He has developed and applied advanced algorithms and protocols for estimating binding free energy using enhanced sampling molecular dynamics (MD) simulations. In anticancer drug discovery, his group leverages this approach to identify molecules capable of inducing synthetic lethality, advancing precision medicine treatments. These studies are carried out in collaboration with hospitals, bridging rational drug design with (pre)clinical applications.
Free online courses from École polytechnique fédérale de Lausanne
EPFL is the Swiss Federal Institute of Technology in Lausanne. The past decade has seen EPFL ascend to the very top of European institutions of science and technology: it is ranked #1 in E…
149 instructors